生物材料在原位构建工程化心肌组织中的应用  

Application of Biomaterials in In Situ Myocardial Tissue Engineering

作　　者：熊鹿[1] 黄晶[1] 

机构地区：[1]重庆医科大学附属第二医院心血管内科,重庆400010

出　　处：《心血管病学进展》2010年第3期454-456,共3页Advances in Cardiovascular Diseases

基　　金：国家自然科学基金重点项目(30527001)资助

摘　　要：采用组织工程技术和生物材料对受损心肌进行修复为心肌梗死治疗开辟了新的途径,现就生物材料联合生物活性分子、干细胞移植在原位构建工程化心肌组织中的应用以及这种治疗方法在充分发挥其临床潜能前仍需克服的科研和临床困难进行综述。The use of tissue engineering technology and biomaterials to repair damaged myocardium has opened up new avenues for the treatment of myocardial infarction.Biomaterials,combined with bioactive molecules and stem cell transplantation,are widely used in in situ myocardial tissue engineering.However,there are still many problems that need to be resolved before this treatment is used in the clinic.Progress made in the use of biomaterials to treat damaged myocardium is summarized in this article.

关 键 词：生物材料 组织工程 心肌梗死 

分 类 号：R318.08[医药卫生—生物医学工程] R542.22[医药卫生—基础医学]